{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:49:53Z","timestamp":1792658993388,"version":"4.5.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00087","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T05:05:15Z","timestamp":1552971915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":67,"title":["Peripheral Demyelinating Diseases: From Biology to Translational Medicine"],"prefix":"10.3389","volume":"10","author":[{"given":"Khidhir","family":"Kamil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Dain","family":"Yazid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruszymah Bt Hj","family":"Idrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0976-3147.127887","article-title":"Central and peripheral demyelination","volume":"5","author":"Mehndiratta","year":"2014","journal-title":"J Neurosci Rural Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000445884","article-title":"Incidence and natural history of idiopathic chronic inflammatory demyelinating polyneuropathy: a population-based study in Iceland","volume":"75","author":"Hafsteinsdottir","year":"2016","journal-title":"Eur Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.22166","article-title":"Charcot-Marie-Tooth disease subtypes and genetic testing strategies","volume":"69","author":"Saporta","year":"2011","journal-title":"Ann Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.11477\/mf.1416200304","article-title":"Molecular mimicry and Guillain-Barr\u00e9 syndrome","volume":"67","author":"Yuki","year":"2015","journal-title":"Brain Nerve"},{"key":"B6","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy In: Roos RP, Editor-in-Chief","volume-title":"MedLink Neurology","author":"Soliven","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1586\/14737175.2015.1017471","article-title":"Therapeutic options in Charcot\u2013Marie\u2013Tooth diseases","volume":"15","author":"Mathis","year":"2015","journal-title":"Expert Rev Neurother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fphys.2017.00693","article-title":"Oxidative stress in oral diseases: understanding its relation with other systemic diseases","volume":"8","author":"Kumar","year":"2017","journal-title":"Front Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/glia.23148","article-title":"Demyelination induced by oxidative stress is regulated by sphingosine 1-phosphate receptors","volume":"65","author":"O'sullivan","year":"2017","journal-title":"Glia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrn1746","article-title":"The origin and development of glial cells in peripheral nerves","volume":"6","author":"Jessen","year":"2005","journal-title":"Nat Rev Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"a020529","DOI":"10.1101\/cshperspect.a020529","article-title":"Schwann cell myelination","volume":"7","author":"Salzer","year":"2015","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/glia.20723","article-title":"Development of the Schwann cell lineage: from the neural crest to the myelinated nerve","volume":"56","author":"Woodhoo","year":"2008","journal-title":"Glia"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1023\/A:1022500301494","article-title":"Myelin formation, structure and biochemistry","author":"Morell","year":"1999","journal-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects"},{"key":"B14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0301-0082(02)00105-3","article-title":"Remyelinating strategies for the treatment of multiple sclerosis","volume":"68","author":"Stangel","year":"2002","journal-title":"Prog Neurobiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/jcp.2005.031195","article-title":"Demyelinating diseases","volume":"59","author":"Love","year":"2006","journal-title":"J Clin Pathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/1744666X.2016.1193006","article-title":"Guillain-Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment","volume":"12","author":"Jasti","year":"2016","journal-title":"Expert Rev Clin Immunol."},{"key":"B19","first-page":"191","article-title":"Guillain-Barr\u00e9 syndrome","volume":"87","author":"Walling","year":"2013","journal-title":"Am Fam Physician"},{"key":"B20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1529-8027.2012.00433.x","article-title":"Recent developments and future directions in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Lehmann","year":"2012","journal-title":"J Peripher Nerv Syst."},{"key":"B21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.24755","article-title":"Mycoplasma pneumoniae triggering the Guillain-Barr\u00e9 syndrome: a case-control study","volume":"80","author":"Meyer Sauteur","year":"2016","journal-title":"Ann Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/cid\/cir074","article-title":"Guillain\u2013Barr\u00e9 syndrome following primary cytomegalovirus infection: a prospective cohort study","volume":"52","author":"Orlikowski","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10096-018-3199-5","article-title":"Guillain-Barr\u00e9 syndrome following varicella-zoster virus infection","volume":"37","author":"Islam","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1371\/journal.pone.0000344","article-title":"Guillain-Barr\u00e9 syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database","volume":"2","author":"Tam","year":"2007","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0165-5728(99)00213-1","article-title":"The immunopathogenesis of Miller Fisher syndrome","volume":"100","author":"Willison","year":"1999","journal-title":"J Neuroimmunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/cen3.12342","article-title":"Pathology of Guillain\u2013barr\u00e9 syndrome","volume":"7","author":"Nakano","year":"2016","journal-title":"Clin Exp Neuroimmunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/0895-4356(95)00557-9","article-title":"Gangliosides and Guillain-Barr\u00e9 syndrome","volume":"48","author":"Raschetti","year":"1995","journal-title":"J Clin Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S1474-4422(06)70603-2","article-title":"Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a prospective study","volume":"5","author":"Durand","year":"2006","journal-title":"Lancet Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"II96","DOI":"10.1007\/s00415-007-2024-3","article-title":"Autonomic dysfunction in Guillain-Barr\u00e9 syndrome and multiple sclerosis","volume":"254","author":"Flachenecker","year":"2007","journal-title":"J Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"Van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2377-13-95","article-title":"Guillain-Barr\u00e9 syndrome: natural history and prognostic factors: a retrospective review of 106 cases","volume":"13","author":"Gonz\u00e1lez-Su\u00e1rez","year":"2013","journal-title":"BMC Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pop.2015.01.001","article-title":"Guillain-Barr\u00e9 syndrome","volume":"42","author":"Ansar","year":"2015","journal-title":"Primary Care Clin Office Pract."},{"key":"B36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ncl.2006.11.003","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"25","author":"Lewis","year":"2007","journal-title":"Neurol Clin."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"K\u00f6ller","year":"2005","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1055\/s-0032-1329194","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside","volume":"32","author":"Peltier","year":"2012","journal-title":"Semin Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","article-title":"Incidence and prevalence of CIDP and the association of diabetes mellitus","volume":"73","author":"Laughlin","year":"2009","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"10","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0896-6273(01)00296-3","article-title":"Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve","volume":"30","author":"Boyle","year":"2001","journal-title":"Neuron"},{"key":"B43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Ann Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"E3689","DOI":"10.1073\/pnas.1619386114","article-title":"Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen- specific treatment option for anti-MAG neuropathy","volume":"114","author":"Herrendorff","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/j.1471-4159.2006.04319.x","article-title":"Myelin-associated glycoprotein (MAG): past, present and beyond","volume":"100","author":"Quarles","year":"2007","journal-title":"J Neurochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ana.410330514","article-title":"Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein","volume":"33","author":"Tatum","year":"1993","journal-title":"Ann Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-016-0532-4","article-title":"Paraproteinemic neuropathy: a practical review","volume":"16","author":"Rison","year":"2016","journal-title":"BMC Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11940-010-0065-x","article-title":"Pathogenesis and treatment of anti-MAG neuropathy","volume":"12","author":"Dalakas","year":"2010","journal-title":"Curr Treat Opt Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1517\/14656566.6.6.945","article-title":"Treatment options for POEMS syndrome","volume":"6","author":"Dispenzieri","year":"2005","journal-title":"Expert Opin Pharmacother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ajh.24171","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"90","author":"Dispenzieri","year":"2015","journal-title":"Am J Hematol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"key":"B52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0002-9343(94)90350-6","article-title":"POEMS syndrome: a study of 25 cases and a review of the literature","volume":"97","author":"Soubrier","year":"1994","journal-title":"Am. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1055\/s-2008-1062264","article-title":"Charcot-Marie-Tooth neuropathies: diagnosis and management","volume":"28","author":"Jani-Acsadi","year":"2008","journal-title":"Semin Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11910-010-0158-7","article-title":"Update on Charcot-Marie-tooth disease","volume":"11","author":"Patzk\u00f3","year":"2011","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/mgg3.106","article-title":"The allelic spectrum of Charcot\u2013Marie\u2013Tooth disease in over 17,000 individuals with neuropathy","volume":"2","author":"DiVincenzo","year":"2014","journal-title":"Mol Genet Genomic Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0960-8966(91)90055-W","article-title":"Duplication in chromosome 17p11","volume":"1","author":"Raeymaekers","year":"1991","journal-title":"Neuromuscular Disord."},{"key":"B57","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.neuron.2007.12.021","article-title":"Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice","volume":"57","author":"Pennuto","year":"2008","journal-title":"Neuron"},{"key":"B58","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature07534","article-title":"Mitofusin 2 tethers endoplasmic reticulum to mitochondria","volume":"456","author":"de Brito","year":"2008","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.17576\/jsm-2018-4711-24","article-title":"Olive and its phenolic compound as the promising neuroprotective agent","volume":"47","author":"Kamil","year":"2018","journal-title":"Sains Malays."},{"key":"B60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Atkinson","year":"2001","journal-title":"Clin Pharmacol Therap"},{"key":"B61","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1590\/0004-282X20160132","article-title":"Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barr\u00e9 syndrome","volume":"74","author":"Ozdemir","year":"2016","journal-title":"Arq Neuropsiquiatr."},{"key":"B62","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.4081\/ni.2017.7032","article-title":"Are cerebrospinal fluid protein levels and plasma neutrophil\/lymphocyte ratio associated with prognosis of Guillain Barr\u00e9 syndrome","volume":"9","author":"Sahin","year":"2017","journal-title":"Neurol. Int."},{"key":"B63","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/00207454.2017.1418342","article-title":"The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain\u2013Barr\u00e9 syndrome","volume":"128","author":"Huang","year":"2018","journal-title":"Int J Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jns.12234","article-title":"Markers for Guillain-Barr\u00e9 syndrome with poor prognosis: a multi-center study","volume":"22","author":"Yamagishi","year":"2017","journal-title":"J Peripher Nerv Syst."},{"key":"B65","doi-asserted-by":"publisher","first-page":"74582","DOI":"10.18632\/oncotarget.12789","article-title":"Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barr\u00e9 syndrome","volume":"7","author":"Mateos-Hern\u00e1ndez","year":"2016","journal-title":"Oncotarget"},{"key":"B66","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneuroim.2016.04.012","article-title":"Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barre syndrome","volume":"295","author":"Nakane","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","article-title":"Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Querol","year":"2017","journal-title":"Sci Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jnnp-2014-309964","article-title":"Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy","volume":"87","author":"Wong","year":"2015","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1756285617746640","DOI":"10.1177\/1756285617746640","article-title":"Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disord."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1515\/cclm-2015-0910","article-title":"Free light chains and heavy\/light chains in monitoring POEMS patients","volume":"54","author":"Altinier","year":"2016","journal-title":"Clin Chem Lab Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"564098","DOI":"10.1155\/2015\/564098","article-title":"Biomarkers of Guillain-Barr\u00e9 syndrome: some recent progress, more still to be explored","volume":"2015","author":"Wang","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B72","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jneuroim.2009.06.012","article-title":"Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid","volume":"214","author":"Tumani","year":"2009","journal-title":"J Neuroimmunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1073\/pnas.78.11.7139","article-title":"Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins","volume":"78","author":"Latov","year":"1981","journal-title":"Proc Natl Acad Sci USA."},{"key":"B75","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ana.410310621","article-title":"Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside","volume":"31","author":"Daune","year":"1992","journal-title":"Ann Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1172\/JCI118526","article-title":"Do anti-ganglioside antibodies cause human peripheral neuropathies?","volume":"97","author":"Quarles","year":"1996","journal-title":"J Clin Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/00207454.2016.1191013","article-title":"Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin- associated glycoprotein (MAG) antibodies","volume":"127","author":"Galassi","year":"2017","journal-title":"Int J Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e009157","DOI":"10.1136\/bmjopen-2015-009157","article-title":"Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study","volume":"5","author":"Misawa","year":"2015","journal-title":"BMJ Open"},{"key":"B79","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ana.410230503","article-title":"Serum antibodies to gangliosides in Guillain-Barr\u00e9 syndrome","volume":"23","author":"Ilyas","year":"1988","journal-title":"Ann Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0022-510X(92)90217-9","article-title":"Antibodies to acidic glycolipids in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"107","author":"Ilyas","year":"1992","journal-title":"J Neurol Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jneuroim.2006.09.013","article-title":"Anti-ganglioside complex antibodies associated with severe disability in GBS","volume":"182","author":"Kaida","year":"2007","journal-title":"J Neuroimmunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00134-005-2736-8","article-title":"Anti- phospholipid antibodies in serum from patients with Guillain-Barr\u00e9 syndrome","volume":"31","author":"Nakos","year":"2005","journal-title":"Intensive Care Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"7831","DOI":"10.1038\/s41598-017-08314-1","article-title":"Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies","volume":"7","author":"Capodivento","year":"2017","journal-title":"Sci Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0165-5728(93)90255-W","article-title":"Antibody responses to P0 and P2 myelin proteins in Guillain-Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy","volume":"46","author":"Khalili-Shirazi","year":"1993","journal-title":"J Neuroimmunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0165-5728(96)00189-0","article-title":"Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"73","author":"Melendez-Vasquez","year":"1997","journal-title":"J Neuroimmunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0165-5728(01)00307-1","article-title":"Investigation of serum response to PMP22, connexin 32 and P0 in inflammatory neuropathies","volume":"116","author":"Kwa","year":"2001","journal-title":"J Neuroimmunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","article-title":"Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"Allen","year":"2005","journal-title":"J Peripher Nerv Syst."},{"key":"B89","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp.2006.106617","article-title":"Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy","volume":"78","author":"Inglis","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B90","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jnnp.2007.123943","article-title":"Immune responses to myelin proteins in Guillain\u2013Barr\u00e9 syndrome","volume":"79","author":"Makowska","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B91","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1529-8027.2000.00022-13.x","article-title":"Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies","volume":"5","author":"Ritz","year":"2000","journal-title":"J Peripher Nerv Syst."},{"key":"B92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1529-8027.2000.00022-12.x","article-title":"Anti-PMP22 antibodies in patients with inflammatory neuropathy","volume":"5","author":"Gabriel","year":"2000","journal-title":"J Peripher Nerv Syst."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e14533","DOI":"10.1371\/journal.pone.0014533","article-title":"Nodes of ranvier and paranodes in chronic acquired neuropathies","volume":"6","author":"Cifuentes-Diaz","year":"2011","journal-title":"PLoS ONE"},{"key":"B94","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain- Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst."},{"key":"B95","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.imlet.2017.03.011","article-title":"sNCAM as a specific marker of peripheral demyelination","volume":"185","author":"Niezgoda","year":"2017","journal-title":"Immunol Lett."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archneur.61.7.1013","article-title":"Anti-GQ1b ganglioside antibody in peripheral nervous system disorders: pathophysiologic role and clinical relevance","volume":"6","author":"Paparounas","year":"2004","journal-title":"Arch Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0092-8674(85)90198-9","article-title":"Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin","volume":"40","author":"Lemke","year":"1985","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0092-8674(92)90591-Y","article-title":"Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons","volume":"71","author":"Giese","year":"1992","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/BF00964676","article-title":"Lipid binding activities of the P2 protein in peripheral nerve myelin","volume":"9","author":"Uyemura","year":"1984","journal-title":"Neurochem Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/PL00012510","article-title":"Myelin sheaths: Glycoproteins involved in their formation, maintenance and degeneration","volume":"59","author":"Quarles","year":"2002","journal-title":"Cell Mol Life Sci."},{"key":"B101","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/B978-0-12-374947-5.00010-9","article-title":"Myelin structure and biochemistry","volume-title":"Basic Neurochemistry","author":"Rasband","year":"2012"},{"key":"B102","first-page":"483","article-title":"Molecular anatomy and genetics of myelin proteins in peripheral nervous system","volume":"186","author":"Snipes","year":"1995","journal-title":"J Anat."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.autrev.2014.08.005","article-title":"Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies","volume":"13","author":"Lim","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.ajpath.2012.06.034","article-title":"Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier","volume":"181","author":"Devaux","year":"2012","journal-title":"Am J Pathol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T05:05:20Z","timestamp":1552971920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":104,"alternative-id":["10.3389\/fneur.2019.00087"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00087","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"article-number":"87"}}